Literature DB >> 7680917

Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells.

J M Kerst1, J G van de Winkel, A H Evans, M de Haas, I C Slaper-Cortenbach, T P de Wit, A E von dem Borne, C E van der Schoot, R H van Oers.   

Abstract

In this study we have examined hFc gamma RI expression during myelopoiesis. Normal bone marrow (BM) cells were found to express hFc gamma RI up to the metamyelocyte stage. A different Fc gamma RI expression pattern was observed in an in vitro model of myelopoiesis. Purified CD34-positive BM cells, cultured for 12 to 14 days with granulocyte colony-stimulating factor (G-CSF), differentiate into a population of mature granulocytic cells. In these cultures, in which hFc gamma RI was virtually absent on the initial CD34-positive BM cells, hFc gamma RI was strongly induced by G-CSF after only 5 days. During final maturation the cells remained hFc gamma RI positive. This expression was confirmed functionally by antibody-sensitized erythrocytes (EA)-rosette assays. Moreover, the mature myeloid cells were found to express mRNA encoding for hFc gamma RI, whereas reverse-transcriptase polymerase chain reaction analysis showed that both hFc gamma RIA and hFc gamma RIB genes were expressed. In contrast, on peripheral blood (PB) polymorphonuclear neutrophil leukocytes (PMN) the in vitro effect of G-CSF as to hFc gamma RI induction was limited. Therefore, we conclude that, with respect to hFc gamma RI expression on PMN, G-CSF acts on myeloid precursor cells rather than on mature cells. This conclusion could be strengthened by in vivo administration of a single dose of G-CSF to a healthy volunteer. After a 12-hour lag time, hFc gamma RI expressing PMNs were detected in the peripheral blood. This study shows that hFc gamma RI is an early myeloid differentiation marker that is lost during normal final maturation. However, committed myeloid progenitor cells can be strongly induced by G-CSF to express hFc gamma RI, ultimately resulting in mature granulocytic cells expressing the high-affinity receptor for IgG. This expression may have important consequences for the functional capacity of these cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680917

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Characterization of the phenotype of human eosinophils and their progenitors in the bone marrow of healthy individuals.

Authors:  Marwan Hassani; Selma van Staveren; Erinke van Grinsven; Marije Bartels; Kiki Tesselaar; Guus Leijte; Matthijs Kox; Peter Pickkers; Nienke Vrisekoop; Leo Koenderman
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

Review 2.  Diagnostics for neonatal sepsis: current approaches and future directions.

Authors:  Pui-Ying Iroh Tam; Catherine M Bendel
Journal:  Pediatr Res       Date:  2017-06-28       Impact factor: 3.756

3.  Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation.

Authors:  Coco de Koning; Julie-Anne Gabelich; Jurgen Langenhorst; Rick Admiraal; Jurgen Kuball; Jaap Jan Boelens; Stefan Nierkens
Journal:  Blood Adv       Date:  2018-03-13

4.  An alternative Fc gamma-receptor ligand: potential role in T-cell development.

Authors:  M Sandor; J Galon; L Takacs; Y Tatsumi; A L Mueller; C Sautes; R G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  Effective in vitro clearance of Porphyromonas gingivalis by Fc alpha receptor I (CD89) on gingival crevicular neutrophils.

Authors:  T Kobayashi; K Yamamoto; N Sugita; A B van Spriel; S Kaneko; J G van de Winkel; H Yoshie
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 6.  Targeting the Fc receptor in autoimmune disease.

Authors:  Xinrui Li; Robert P Kimberly
Journal:  Expert Opin Ther Targets       Date:  2014-03       Impact factor: 6.902

7.  Activated phenotype in neutrophils and monocytes from patients with primary proliferative polycythaemia.

Authors:  N B Westwood; E R Copson; L A Page; A R Mire-Sluis; K A Brown; T C Pearson
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

8.  CD64 surface expression on neutrophils and monocytes is significantly up-regulated after stimulation with granulocyte colony-stimulating factor during CHOP chemotherapy for patients with non-Hodgkin's lymphoma.

Authors:  Yasutaka Kakinoki; Hiroya Kubota; Yasushi Yamamoto
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

9.  Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

Authors:  I A Heijnen; M J van Vugt; N A Fanger; R F Graziano; T P de Wit; F M Hofhuis; P M Guyre; P J Capel; J S Verbeek; J G van de Winkel
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

10.  Monocyte CD64 or CD89 targeting by surfactant protein D/anti-Fc receptor mediates bacterial uptake.

Authors:  Paul J Tacken; Joseph J Batenburg
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.